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Background: This study aimed to map the distribution of Taenia solium taeniosis/cysticercosis and the co-distribution
with schistosomiasis in Africa. These two major neglected tropical diseases are presumed to be widely distributed in
Africa, but currently the level of co-distribution is unclear.
Methods: A literature search on T. solium taeniosis/cysticercosis was performed to compile all known studies on
the presence of T. solium and apparent prevalence of taeniosis and porcine cysticercosis in Africa. Studies were
geo-referenced using an online gazetteer. A Bayesian framework was used to combine the epidemiological data
on the apparent prevalence with external information on test characteristics to estimate informed district-level
prevalence of taeniosis and porcine cysticercosis. Districts with T. solium taeniosis/cysticercosis presence were
cross-referenced with the Global Neglected Tropical Diseases Database for schistosomiasis presence.
Results: The search strategies identified 141 reports of T. solium in Africa from 1985 to 2014 from a total of 476 districts
in 29 countries, 20 with porcine cysticercosis, 22 with human cysticercosis, and 16 with taeniosis, in addition to 2
countries identified from OIE reports. All 31 countries were considered, on national scale, to have co-distribution with
schistosomiasis. Presence of both parasites was confirmed in 124 districts in 17 countries. The informed prevalence of
taeniosis and porcine cysticercosis were estimated for 14 and 41 districts in 10 and 13 countries, respectively.
Conclusions: With the paucity of data, T. solium infection is grossly under-reported and expected to be more widespread
than this study suggests. In areas where co-distribution occurs there is a need for increased emphasis on evaluation
of integrated intervention approaches for these two helminth infections and allocation of resources for evaluating the
extent of adverse effects caused by mass drug administration.
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The major neglected tropical diseases, Taenia solium
taeniosis/cysticercosis and schistosomiasis caused by
Schistosoma mansoni or S. haematobium are presumed to
be widely distributed in Africa. Taenia solium taeniosis/
cysticercosis has been reported as an emerging disease in
different regions of Africa [1, 2], but currently the exact
distribution remains unclear. Reported prevalences of
T. solium taeniosis and cysticercosis in African countries
are not extensive and are further complicated by the lack
of ‘gold standard’ tests for diagnosis. Diagnosis has so far* Correspondence: braae@sund.ku.dk
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sensitivity and specificity [3–5]. Therefore, estimating in-
formed prevalence is important to determine the actual
disease burden. Informed prevalence is an estimation of
the true prevalence based on the apparent prevalence
while factoring in the imperfections in sensitivity and spe-
cificity of the diagnostic tests used. The distribution of
schistosomiasis in Africa has been more extensively inves-
tigated than T. solium taeniosis/cysticercosis and this has
allowed for country level prevalence and risk estimation of
schistosomiasis for all African countries [6].
The World Health Organization (WHO) is aiming for
elimination of schistosomiasis by 2020 and the road map
for elimination of T. solium taeniosis/cysticercosis is under
consideration by the WHO [7]. The WHO strategy foricle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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istration (MDA) of preventive chemotherapy as the main
intervention tool. The WHO advocates that MDA against
schistosomiasis will reduce morbidity and decrease trans-
mission, which might also carry the added benefit of con-
trolling other infections in co-endemic areas such as
T. solium taeniosis/cysticercosis [7]. A way forward for
control of T. solium is integration with schistosomiasis
control programmes. However, the potential benefit of an
integrated control effort against the two parasites has yet
to be evaluated. The anthelminthic drug used against
schistosomiasis is praziquantel (PZQ) because of its safety
profile, easy administration, and mild side-effects [7]. The
current recommended dose of PZQ for treatment of
schistosomiasis is 40 mg/kg as a single dose [8]. PZQ has
proved highly efficacious against taeniosis at a dose of 5–
10 mg/kg [9], and the drug can therefore be used against
both parasites. However, the dose recommended for schis-
tosomiasis treatment may increase the risk of seizures in
people who are suffering from human cysticercosis where
the larvae are lodged in the central nervous system (neu-
rocysticercosis, NCC). Even a single dose, lower than that
recommended for schistosomiasis treatment, has been re-
ported to induce seizures [10]. Flisser and colleagues [11]
reported suspected cases of NCC based on clinical signs
following treatment with 5 mg/kg PZQ, and in a follow-
up of 2452 participants subjected to an MDA using PZQ
at 5 mg/kg where of 1.3 % reported complaints of severe
headache after treatment. Although MDA has been widely
applied for control of schistosomiasis in Africa, the safety
of PZQ in MDA in communities where schistosomiasis
and NCC coexist is yet to be systematically assessed.
The distribution of T. solium taeniosis/cysticercosis in
Africa is unclear and up-to-date prevalence maps do not
exist. The distribution of schistosomiasis is also to some
extent uncertain, but through the work of the Global
Neglected Tropical Diseases Database (GNTD; http://
www.gntd.org), a prevalence map based on more than
20,000 locations can be created. The database is con-
tinuously updated with the goal to use the information
for public health campaigns against schistosomiasis.
With the launch of online virtual globes such as Google
Earth, online gazetteers have become a useful tool for
geo-referencing of locations and also disease distribu-
tion. The GNTD has used online gazetteers in order
to geographically locate the distribution of schistosomia-
sis [12], which in turn have been utilised for modelling
past and future distribution maps of infection [13–15].
This paper aims to compile the available information on
T. solium taeniosis/cysticercosis in Africa and use the in-
formation to estimate the informed prevalence of taenio-
sis and porcine cysticercosis on a district level, and
determine districts were co-distribution of T. solium tae-
niosis/cysticercosis and schistosomiasis occurs.Methods
Literature search
The following data were included in this study 1) peer-
reviewed studies of T. solium taeniosis/cysticercosis in
Africa, 2) “grey literature” on T. solium taeniosis/cysticer-
cosis presence in Africa which consisted of informally pub-
lished written materials such as reports and theses, 3)
official reports of national pig populations in Africa avail-
able through national census data and FAOSTAT [16],
the statistical database of the Food and Agriculture
Organization of the United Nations, 4) porcine cysticerco-
sis reports from the World Organisation for Animal Health
(OIE), and 5) the schistosomiasis prevalence map currently
used by the WHO for assessing MDA intervals [17].
We performed a literature search using PubMed (http://
www.ncbi.nlm.nih.gov/pubmed/) with date restriction from
01-01-1985 to 05-01-2015 using the following search term:
(solium OR Tapeworm OR Taeniasis OR Taeni* OR Tae-
niosis OR Neurocysticercosis OR Cysticerc* OR cellulosae)
AND (Algeria OR Angola OR Benin OR Botswana OR
Burkina Faso OR Burundi OR Cameroon OR Central
African Republic OR Chad OR Congo OR Zaire OR
Cote d’Ivoire OR Ivory Coast OR Djibouti OR Egypt OR
Equatorial Guinea OR Eritrea OR Ethiopia OR Gabon
OR Gambia OR Ghana OR Guinea OR Guinea-Bissau
OR Kenya OR Lesotho OR Liberia OR Libya OR
Madagascar OR Malawi OR Mali OR Mauritania OR
Morocco OR Mozambique OR Namibia OR Niger
OR Nigeria OR Rwanda OR Senegal OR Sierra Leone
OR Somalia OR South Africa OR South Sudan OR
Sudan OR Swaziland OR Tanzania OR Togo OR Tunisia
OR Uganda OR Zambia OR Zimbabwe). We also searched
other databases such as Google Scholar (http://scholar.
google.com), Thomson Reuter’s Web of Knowledge
(http://www.wokinfo.com), Cab Direct (http://www.cab
direct.org), Société de Pathologie Exotique (http://www.
pathexo.fr/), ProMED (http://www.isid.org), and African
Journals Online (http://www.ajol.info) using the following
keywords: “Taenia solium”, “porcine cysticercosis”, “Cysti-
cercus cellulosae”, “neurocysticercosis”, “human cysticerco-
sis”, “taeniosis”, and “taeniasis”. In addition, references
found in suitable articles were also investigated to compile
all known studies on presence of T. solium and prevalence
of taeniosis and porcine cysticercosis.
Data extraction
Presence of T. solium in this study was defined as a doc-
umented case of disease related to the T. solium tape-
worm, whether it was diagnosed and documented as
porcine cysticercosis, taeniosis, or human cysticercosis.
Initially we reviewed all titles and abstracts, if accessible,
and excluded studies from outside Africa, studies based
on questionnaire only, environmental studies, and stud-
ies with no reference to geographical location. Authors
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tacted. The remaining studies were excluded if full-text
was not available or if based on experimental studies
where location of infection could not be established
(Fig. 1). Studies on human cysticercosis were only in-
cluded if the authors provided approximate location of
where the patient presumably caught the infection. For
example, Pönnighaus and colleagues [18] reported a case
of cutaneous cysticercosis in Malawi, where it was be-
yond doubt that the disease had been acquired within
the country. Other reports such as NCC cases suspected
to be autochthonous but not confirmed were omitted. In
order to reduce the risk of including T. saginata infec-
tions, studies reporting taeniosis, but without confirm-
ation of the T. solium tapeworm, were only included if
reports of porcine cysticercosis could be found for the
respective country or if the OIE reported porcine cysti-
cercosis to be present in the respective country.
Taenia solium taeniosis/cysticercosis cases were geo-
referenced by extracting geographic information on the
study quoted in the literature. If no geographic coordi-
nates were provided by the authors, the geographic loca-
tion was found by using the online gazetteer ‘Geonames’
(http://geonames.org). Distribution of schistosomiasis was
extracted as point data from the GNTD and overlaid onFig. 1 Diagram of literature search and countries where the studies were cthe district-level occurrence of T. solium taeniosis/cysti-
cercosis to determine districts with co-distribution.
Informed district-level prevalence of taeniosis and
porcine cysticercosis was estimated from apparent
prevalence estimates extracted from the literature and
external information on the sensitivity and specificity of
the applied diagnostic tests. Data was only extracted if
applied diagnostic tests, denominators and the number
of positive subjects were provided. If multiple studies
existed from the same second-level administrative div-
ision, the mapping was based on survey year (most re-
cent), and then highest informed prevalence (Fig. 2). For
studies were informed prevalence could be estimated
based on multiple test assessment [19], this more in-
formed estimate was preferred over the corresponding
single test estimates. Studies with sample sizes of less
than 30 individuals were excluded. Bayesian inference
was used to obtain the informed prevalence estimates
[20], using the functions in the R package prevalence
version 0.3.0 [21]. The parameters for the probabilistic
constraints in terms of sensitivity and specificity of the
diagnostic tests used were obtained from key papers
using the 95 % confidence intervals reported (Table 1).
Further information and source code for both the sin-
gle and multiple test informed prevalence assessmentsarried out
Fig. 2 Flow chart of the selection of literature for the informed prevalence estimations
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lence estimation.
Data on the African pig population were extracted
from national livestock census reports or FAOSTAT
database if national census data were missing, and di-
vided with the countries human population obtained
from the UN to yield a per capita pig population [22].
Data on recent (2005 to 2014) reports of porcine cysticer-
cosis that have been submitted to the OIE were extracted
from the OIE database WAHID Interface [23]. Reports
from the database are in 6 months intervals with disease
status divided into 5 categories: disease was present,
suspected but not confirmed, not reported during this
period, never reported, and no information available.
We have pooled the data into one ‘disease status’ during
the period 2005 to 2014, ranking the five categories in
the following order 1) disease was present, 2) suspectedTable 1 Parameters used for the probabilistic constraints for sensitiv
95 % confidence intervals reported in key papers
Test Disease
Lingual examination Porcine cysticercosis
Post-mortem Porcine cysticercosis
Ag-ELISA (B158/B60) Porcine cysticercosis
Ag-ELISA (HP10) Porcine cysticercosis
Coprology Taeniosis
Copro-Ag-ELISA Taeniosis
aTest only genus specificbut not confirmed, 3) not reported during this period,
4) never reported, and 5) no information available.
Results
The search strategies identified 141 reports of T. solium
taeniosis/cysticercosis in Africa from 1985 to 2014, writ-
ten in English, French, Portuguese, Italian, Danish, and
German. The reports confirmed presence of T. solium
taeniosis/cysticercosis in 476 second-level administrative
units (i.e., districts) or equivalent from 29 African coun-
tries, with porcine cysticercosis reported in 20 countries,
human cysticercosis reported in 22 countries, and taeniosis
reported in 16 countries of which only 3 countries had
studies confirming T. solium taeniosis cases (Table 2). No
attempts were made to differentiate between T. solium and
T. saginata infections in the reports from the remaining 13
countries. For additional 2 countries (Côte d’Ivoire [24]ity and specificity of the different diagnostic tests using the
Sensitivity (%) Specificity (%) Reference
16.1–21.0 90.0–100 [4]
22.1–38.7 90.0–100 [4]
64.5–86.7 91.2–94.7 [4]
52.7–84.7 44.6–85.1 [54, 55]
11.1–96.5 99.5–100a [56]
61.9–98.0 90.0–93.8 [56]
Table 2 Presence of Taenia solium cysticercosis recorded in African countries from 1985 to 2014. Taenia solium taeniosis was not
confirmed unless otherwise stated
Country Porcine cysticercosis Taeniosis Human cysticercosis No of References
Angola [57] 1
Benin [58] [59–61] 4
Burkina Faso [62] [63–69] 8
Burundi [70] [70] [41, 70–73] 5
Cameroon [74–78] [79, 80]a [79, 81–87] 7
Central African Republic [88] 1
Chad [78] 1
Côte d’Ivoire [24] 1
Democratic Republic of Congo [89, 90] [38] [38] 3
Egypt [91] 1
Gabon [92] 1
Gambia [93] 1
Ghana [94] [95] 2
Guinea-Bissau [96, 97] 2
Kenya [30, 98–100] [95, 101] 6
Madagascar [102–104] [105] [106–111] 10
Malawi [18, 112] 2
Mali [113] 1
Mozambique [51, 114, 115] [116]a [116–118] 6
Namibia [25] 1
Nigeria [119–123] [120, 123–127] [40, 128, 129] 12
Rwanda [130] 1
Senegal [93] [131, 132] [132] 3
South Africa [55] [133, 134] [95, 133, 135–140] 10
Tanzania [28, 29, 31, 141–150] [39, 151]a [39, 95, 152–156] 21
Togo [157] [157] [158–161] 5
Uganda [162–167] [168] [95, 169] 9
Zambia [4, 52, 170–172] [36, 173–175] [36, 42, 173, 174, 176, 177] 12
Zimbabwe [178] [179, 180] 3
a Confirmed Taenia solium taeniosis cases
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cluded based on OIE reports of porcine cysticercosis. This
was for Côte d’Ivoire further supported by older literature
documenting T. solium presence [26], but since neither
studies on porcine cysticercosis nor human cysticercosis
could be found in the literature search for Namibia, the
presence of T. solium based on taeniosis is therefore uncer-
tain. In Lesotho and Swaziland, no official information was
found but T. solium presence in Lesotho has been men-
tioned in literature [27]. However, this was not deemed
sufficient to be included in this study. There is a paucity
of data from North Africa, but presumably due to the
cultural/religious beliefs prevailing in the region, low
prevalence could be expected. However, since pigs are kept
in the region, we cannot assume the region is disease free.According to the ranking of OIE’s reports of porcine
cysticercosis for 2005–2014, the disease was present
in 18 African countries and additionally suspected in
three: Equatorial Guinea, Kenya, and Tanzania. For both
Kenya and Tanzania, literature confirms the presence of
T. solium during this period [28–31], but no data exist
from Equatorial Guinea. This indicates insufficient na-
tional reporting to the OIE. In 2 of the 18 countries with
porcine cysticercosis according to the OIE, i.e., Congo
and Niger, no other documentation of T. solium pres-
ence could be found.
Figure 3 shows the presence of T. solium taeniosis/cys-
ticercosis on national and district levels on the African
continent and Madagascar. Data are not readily available
for many African countries and in countries where data
Fig. 3 African countries and districts where Taenia solium taeniosis/cysticercosis has been confirmed from 1985 to 2014
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known. Importantly there are 10 African countries
where pig keeping is known to take place, but in which
no data exists for the presence of T. solium. Although,
in three of these countries the pig population per capita
is relatively low (Fig. 4).
Figure 5 shows the presence of T. solium taeniosis/
cysticercosis in Africa super-imposed onto African coun-
tries where the WHO recommended MDA against schis-
tosomiasis with three different treatment intervals based
on prevalence; high (≥50 %), medium (≥10 to <50 %), and
low (<10 %). High prevalence areas fall under the recom-
mendation of annual MDA of PZQ to all school-aged
children and populations at risk. In medium prevalence
areas biennially MDA of PZQ to all school-aged children
are recommended, and in low prevalence areas all school-
aged children should be treated twice during their
schooling. In all 31 countries where T. solium taeniosis/
cysticercosis was found, MDA was also recommended for
control of schistosomiasis. Taenia solium has been con-
firmed in four countries (Ghana, Madagascar, Mozambique,
and Tanzania) out of the five schistosomiasis high preva-
lence countries. No information is available for the fifth
country (Sierra Leone) in terms of T. solium distribution,
but pigs are present (Fig. 4). The WHO MDA recommen-
dations represent an estimate of the mean schistosomiasisburden within a country. By overlaying the GNTD data on
schistosomiasis with the district data on T. solium distribu-
tion, we found co-distribution in 124 out of the 476 dis-
tricts were T. solium occurred. In these districts the GNTD
data showed a mean schistosomiasis prevalence of 23.1 %,
with a mean maximum prevalence of 49.6 %.
Figures 6 and 7 represent the informed prevalence
estimated for T. solium taeniosis and porcine cysticerco-
sis, respectively, based on the studies that fulfilled the
criteria for Bayesian inference (Table 3), and the selec-
tion criteria. Informed prevalence for taeniosis was cal-
culated for 14 districts in 10 countries out of the 16
countries in which taeniosis were found (Fig. 6). For
Côte d’Ivoire, Madagascar, Mozambique, Namibia, Togo,
and Zimbabwe the literature did not contain the neces-
sary epidemiological information and was excluded from
the analysis. Informed prevalence for porcine cysticerco-
sis was estimated for 41 districts in 13 out of the 20
countries in which porcine cysticercosis were confirmed
(Fig. 7). Finally, detailed epidemiological data on porcine
cysticercosis infection were missing from 7 (65 %) out of
the 20 endemic countries based on the literature.
Discussion
Taenia solium taeniosis/cysticercosis was confirmed in
476 districts in 29 African countries based on the
Fig. 4 African pig population per capita on a national level in 2011. National pig populations were obtained from census reports or FAOSTAT
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2005 to 2014, the parasite is present in additional two
countries, totalling 31 endemic countries in Africa. The
findings correspond well to the WHO risk map for cysti-
cercosis previously published [32], but have a much
higher level of accuracy with distribution on district level
in certain areas. With only 141 references identified
from surveys in Africa, occurrence is probably grossly
underreported. Several countries e.g. Guinea, Sierra
Leone, and Liberia, with relatively large porcine popula-
tions still need to be investigated for T. solium presence,
which emphasises the need for more research on disease
distribution. However, this is complicated by the fact
that T. solium has a focal distribution [33]. Pig keeping
is far from evenly distributed across the African contin-
ent, nor within single countries, region or even districts.
In all 31 countries where T. solium occurrence was
documented, schistosomiasis and T. solium taeniosis/
cysticercosis can be considered to co-exist. Data on the
distribution of T. solium is sparse on the district level
and more data is essential to construct more accurate
co-distribution maps, but nonetheless co-distribution
was confirmed in 124 districts in 17 countries. Identify-
ing co-endemic clusters on the same administrative level
as MDA is carried out in the respective countries will
enable identification of communities at risk of adverseeffects from treatment with PZQ due to NCC. Even at
village level significant variation in disease distribution is
expected for both schistosomiasis and T. solium taenio-
sis/cysticercosis, as transmission of the disease is
dependent on the presences of the respective intermedi-
ate hosts. This can result in large differences in disease
prevalence within small geographical areas. However,
since inadequate sanitation is an important risk factor
for both parasites, frequent overlaps would be expected.
According to the WHO, preventive chemotherapy
against schistosomiasis is required in some districts of
all sub-Saharan countries, except Lesotho where the dis-
ease is not endemic [17]. More than 240 million people
in Africa were in need of preventive chemotherapy
against schistosomiasis in 2013 and just over 130 million
of these were school-aged children [34]. School-aged
children typically make-up a relatively large proportion
of the total population within African countries and are
considered the main group at risk for severe schistosom-
iasis morbidity and main contributors to egg excretion
[35]. Taeniosis is however more equally distributed
across age groups within the population [36], thus MDA
of PZQ to school-aged children might therefore not be
sufficient to significantly lower Taenia egg excretion
within a community even though school-aged children
make-up a large proportion of the population [37].
Fig. 5 Co-distribution of Taenia solium infections in humans and/or pigs and schistosomiasis in Africa based on studies from 1985 to 2014
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of MDA for schistosomiasis in communities where T.
solium taeniosis/cysticercosis and schistosomiasis are
co-distributed, which is highly warranted. Since the geo-
graphical distribution of T. solium remains to be fully
elucidated in most African countries, the risk of adverse
effects could be significantly underestimated. Several
studies in Africa have confirmed the presence of human
cysticercosis and specifically NCC in areas where schis-
tosomiasis is endemic [36, 38–41]. Although NCC is
considered more common in adults [42], children are
also infected and in South Africa children down to the
age of three have been found to suffer from NCC [43].
On-going control programmes in communities where
pigs are kept or consumed, should be systematically
monitored for adverse events that may incur from NCC
in order to make precautionary implementations for fu-
ture MDAs, such as determining prevalence of NCC in
communities. Therefore, the number of pigs present in
the communities, regions, and countries is an important
key figure to obtain. Currently few African countries
have performed a national census on livestock which
makes the presumed rough estimates on national pig
populations in Africa from FAOSTAT the only data
available. However, the problem of NCC is not necessar-
ily confined to areas where pigs are kept. Numerousaccounts have shown that persons who neither raise pigs
nor consume pork are also at risk of cysticercosis
as people can accidently ingest T. solium eggs after com-
ing into direct or indirect contact with tapeworm car-
riers, irrespective of their own cultural and religious
practices or the presence of pigs [44–47]. Therefore,
communication between the veterinary and public
health sector is crucial for local authorities to get insight
into the consequences of applying MDA to communities
where schistosomiasis and T. solium taeniosis/cysticer-
cosis are co-endemic.
Findings from the literature search indicate a discrep-
ancy between the reports on the presence of porcine
cysticercosis stated in the literature and that of which
has been reported to the OIE. This may be due to por-
cine cysticercosis not being an international notifiable
disease, which may lead to inconsistencies in reporting
to the OIE by member states. There is a need to improve
communication between the scientific community and
OIE in addition to the respective member states from
Africa to alleviate this problem.
The informed prevalences of taeniosis and porcine
cysticercosis should be regarded as best estimates rather
than absolute truths. Sensitivity and specificity are not
necessarily intrinsic to the specific diagnostic test used,
but affected by external factors [48], or by the intensity
Fig. 6 Informed prevalence of taeniosis in Africa from 1983 to 2010
Fig. 7 Informed prevalence of porcine cysticercosis in Africa from 1985 to 2013
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Table 3 Studies included in the calculation of informed
prevalence of Taenia solium taeniosis and porcine cysticercosis
by Bayesian inference
Country Porcine cysticercosis Taeniosis
Burkina Faso [62]
Burundi [70] [70]
Cameroon [74–78] [80]a
Chad [78]
Democratic Republic of Congo [90] [38]
Ghana [94]
Guinea-Bissau [96, 97]
Kenya [30, 98–100]
Mozambique [51]
Nigeria [119–121, 123] [120]
Senegal [132]
South Africa [54] [133]
Tanzania [29, 31, 141, 142,
144, 149, 150]
[39, 151]a
Uganda [167] [168]
Zambia [4, 170–172] [36]
a Cases of Taenia solium taeniosis confirmed
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[49]. The Bayesian inference does however give the best
possible comparison and thereby provides a rough over-
view of the disease burden within certain areas in the af-
fected countries. Unfortunately, it does not provide any
information on the T. solium cysticercosis burden for
any entire nation. This requires more detailed nation-
wide epidemiological surveys [50].
Allowing pigs to roam freely is a well-known risk fac-
tor for porcine cysticercosis [51, 52], but production
type and management were not considered in the study.
Likewise, no differentiation was made between studies
performed at slaughter slabs and farms. There is consen-
sus that pigs in endemic African countries often are
screened for cysticercosis by tongue examination before
being sent for slaughter, resulting in higher apparent
prevalence on farms compared to slaughter slabs. This
causes bias in the surveys performed at slaughter slabs,
which will underestimate the prevalence of porcine cys-
ticercosis, because pigs with high intensity infections
have been eliminated from the sample.
Pinpointing the origin of T. solium cases is difficult be-
cause taeniosis is often asymptomatic and symptoms of
NCC often occur between 2 and 5 years after infection
[53]. Thus, the subject would therefore require accurate
long-term recollection of where and when the infection
might have been contracted, and depending on travel his-
tory of the infected person the infection might not have
been acquired at the same place as they were surveyed.Conclusion
Although T. solium is reported from the majority of
African countries it is still grossly under-reported and for
many areas the co-distribution with schistosomiasis on
district level is still unknown. In areas where T. solium
and schistosomiasis is co-distributed, an increased em-
phasis should be put on evaluating an integrated interven-
tion approach for these two helminth infections. Resources
should be allocated to evaluate the extent of adverse
effects caused by the MDA of PZQ as preventive treat-
ment in areas where people suffer from NCC. On-going
control programmes should therefore be monitored,
but reaching the goal of eliminating T. solium will re-
quire a One Health approach addressing both human
and animal health.
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